The production of interferon by malignant plasma cells from patients with multiple myeloma.
D001854:Bone Marrow Cells; D002478:Cells, Cultured; D046508:Culture Techniques; D005347:Fibroblasts / Q000276:immunology; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis; D007372:Interferons / Q000096:biosynthesis*; D037102:Lectins; D007930:Leucine / Q000378:metabolism; D008259:Macroglobulins / Q000032:analysis; D009101:Multiple Myeloma / Q000276:immunology / Q000378:metabolism*; D009194:Myeloma Proteins / Q000032:analysis; D010950:Plasma Cells / Q000378:metabolism*; D011863:Radioimmunoassay; D014316:Tritium; D014721:Vesicular stomatitis Indiana virus / Q000276:immunology; D010948:Viral Plaque Assay; D008258:Waldenstrom Macroglobulinemia / Q000276:immunology / Q000378:metabolism
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007136:Immunoglobulins; D037102:Lectins; D008259:Macroglobulins; D009194:Myeloma Proteins; D014316:Tritium; D007372:Interferons; D007930:Leucine